Chillarón JJ. Hirsutism: diagnosis and treatment. FMC Form Med Contin Aten Primaria. 2020;27:11–3 (in Spanish).
Zhang T, Xu Y. Exploration of the clinical pathway for etiological diagnostics of androgen excess in female. Zhonghua Yi Xue Za Zhi. 2023;103:1016–21 (in Chinese).
Witchel SF. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. 2017;30:520–34.
Article PubMed PubMed Central Google Scholar
Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-inositol and oral contraceptives. Eur Rev Med Pharmacol Sci. 2021;25:7476–85.
Sıklar Z, Berberoğlu M, Çamtosun E, Kocaay P. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence. J Pediatr Adolesc Gynecol. 2015;28:78–83.
Sardana K, Muddebihal A, Sehrawat M, Bansal P, Khurana A. An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert Rev Endocrinol Metab. 2024;19:111–28.
Article CAS PubMed Google Scholar
Esquivel-Zuniga MR, Kirschner CK, McCartney CR, Burt Solorzano CM. Non-PCOS hyperandrogenic disorders in adolescents. Semin Reprod Med. 2022;40:42–52.
Article CAS PubMed PubMed Central Google Scholar
Bizuneh AD, Joham AE, Teede H, Mousa A, Earnest A, Hawley JM, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Hum Reprod Update. 2025;31:48–63.
Article CAS PubMed Google Scholar
Makrantonaki E, Zouboulis CC. Hyperandrogenism, adrenal dysfunction, and hirsutism. Hautarzt. 2020;71:752–61 (in German).
Article CAS PubMed Google Scholar
Reinehr T, Dieris B. New clinical practice guideline for evaluation and treatment of children and adolescents with obesity: paradigm shifts. Lancet Diabetes Endocrinol. 2023;11:222–3.
Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021;3:100085.
Kiconco S, Earnest A, Enticott J, Hart R, Mori TA, Hickey M, et al. Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis. Eur J Endocrinol. 2023;188:494–502.
Article CAS PubMed Google Scholar
Rojewska P, Meczekalski B, Bala G, Luisi S, Podfigurna A. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach. Gynecol Endocrinol. 2022;38:537–42.
Article CAS PubMed Google Scholar
Nowak-Ciołek M, Stachowiak JJ, Krok K, Sokal J, Malczyk Ż, Skrzyńska K, et al. Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles. Front Endocrinol (Lausanne). 2025;16:1579217.
Tay CT, Hart RJ, Hickey M, Moran LJ, Earnest A, Doherty DA, et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18:389.
Article PubMed PubMed Central Google Scholar
Conlon JL, Malcolm S, Monaghan M. Diagnosis and treatment of polycystic ovary syndrome in adolescents. JAAPA. 2021;34:15–22.
Akgül S, Düzçeker Y, Kanbur N, Derman O. Do different diagnostic criteria impact polycystic ovary syndrome diagnosis for adolescents? J Pediatr Adolesc Gynecol. 2018;31:258–62.
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108:2447–69.
Article CAS PubMed PubMed Central Google Scholar
Azziz R, Amiri M, Bril F, Joham AE, Kelestimur F, Ottey S, et al. Approach to the patient: hirsutism. J Clin Endocrinol Metab. 2025. https://doi.org/10.1210/clinem/dgaf226.
Article PubMed PubMed Central Google Scholar
Merke DP, Auchus RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 2020;383:1248–61.
Article CAS PubMed Google Scholar
Auer MK, Nordenström A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet. 2023;401:227–44.
Article CAS PubMed Google Scholar
Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:4043–88.
Article PubMed PubMed Central Google Scholar
Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update. 2017;23:580–99.
Article CAS PubMed Google Scholar
Falhammar H, Nordenström A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015;50:32–50.
Article CAS PubMed Google Scholar
Rowe NE, Kumar R, Schieda N, Siddiqi F, McGregor T, McAlpine K, et al. Diagnosis, management, and follow-up of the incidentally discovered adrenal mass: CUA guideline endorsed by the AUA. J Urol. 2023;210:590–9.
Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril. 2006;86(5 Suppl 1):S241–7.
Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382:937–50.
Article CAS PubMed Google Scholar
Bavaresco A, Mazzeo P, Lazzara M, Barbot M. Adipose tissue in cortisol excess: what Cushing’s syndrome can teach us? Biochem Pharmacol. 2024;223:116137.
Article CAS PubMed Google Scholar
Nowotny HF, Braun L, Reisch N. The landscape of androgens in Cushing’s syndrome. Exp Clin Endocrinol Diabetes. 2024;132:670–7.
Article CAS PubMed Google Scholar
Nowotny HF, Braun L, Vogel F, Bidlingmaier M, Reincke M, Tschaidse L, et al. 11-oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing’s disease. Eur J Endocrinol. 2022;187:663–73.
Article CAS PubMed PubMed Central Google Scholar
Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2019;502:214–21.
Hernández-Jiménez JL, Barrera D, Espinoza-Simón E, González J, Ortíz-Hernández R, Escobar L, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2021;38:2–9.
Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, De Courten B, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018;89:628–33.
Comments (0)